The negotiations took several months and involved moving the deadline several times, the Financieele Dagblad reported. DSM-Firmenich will retain a 20% stake in the company.

The business, which will have 8,000 workers, will be divided into two units, both based in Switzerland: Solutions Company and Essential Products Company, which will focus on vitamins.

The two companies will continue to work closely together, especially with regard to vitamin supply in the animal nutrition and health value chain, DSM-Firmenich said.

The Dutch-Swiss combine said in 2024 that it wanted to sell the animal feed arm, which generated sales of €3.5 billion last year.

The transaction follows the sale of the company’s feed enzymes activities to Novonesis for €1.5 billion in 2025 and “marks the final strategic step for DSM-Firmenich to become a fully focused consumer company active in nutrition, health and beauty,” the company said in a statement.

DSM-Firmenich has also announced a new share buyback programme totalling €500 million. The company?s shares fell some 4% on the Amsterdam stock exchange in the wake of the sale announcement.

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Our thanks to everyone who donates regularly to Dutch News. It costs money to produce our daily news service, our original features and daily newsletters, and we could not do it without you.

If you have not yet made a donation, or did so a while ago, you can do so via these links

The DutchNews.nl team

Please help us making DutchNews.nl a better read by taking part in a short survey.